Finance

Lists
002399:SHE
Shenzhen Hepalink Pharma Group Co Ltd
CNÂ¥9.43
+1.29%
(+0.12) 1D
Nov 4, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002399...
Open
CNÂ¥9.37
High
CNÂ¥9.45
Low
CNÂ¥9.17
Mkt. cap
12.36B
Avg. vol.
3.34M
Volume
4.29M
Dividend
1.54%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
72.90
52-wk high
CNÂ¥12.68
52-wk low
CNÂ¥8.50
EPS
CNÂ¥0.13
Shares outstanding
1.25B
No. of employees
2K
Open
CNÂ¥9.37
High
CNÂ¥9.45
Low
CNÂ¥9.17
Mkt. cap
12.36B
Avg. vol.
3.34M
Volume
4.29M
Dividend
1.54%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
72.90
52-wk high
CNÂ¥12.68
52-wk low
CNÂ¥8.50
EPS
CNÂ¥0.13
Shares outstanding
1.25B
No. of employees
2K
News stories
From web sources and news partners
About Shenzhen Hepalink Pharma Group Co Ltd
CEO-
Employees2.1K
FoundedApr 21, 1998
Headquarters-
SectorPharmaceutical industry
Industry-
Websitehepalink.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.28B
1.33B
1.25B
1.22B
Cost of goods sold
900.40M
876.31M
826.48M
789.21M
Cost of revenue
900.40M
876.31M
826.48M
789.21M
Research and development expenses
50.33M
36.44M
45.89M
50.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
252.73M
209.31M
238.09M
223.41M
Operating expense
336.08M
263.62M
301.09M
255.72M
Total operating expenses
1.24B
1.14B
1.13B
1.04B
Operating income
48.03M
190.92M
121.10M
172.40M
Other non operating income
-254.18M
-122.99M
121.83M
-231.19M
EBT including unusual items
-239.36M
207.68M
72.85M
127.95M
EBT excluding unusual items
-97.72M
93.38M
76.27M
111.16M
Income tax expense
-29.37M
20.31M
-14.68M
9.52M
Effective tax rate
12.27%
9.78%
-20.15%
7.44%
Other operating expenses
16.33M
8.11M
7.92M
1.26M
Net income
-204.09M
187.57M
87.71M
118.61M
Net profit margin
-15.89%
14.09%
7.02%
9.74%
Earnings per share
-
-
-
-
Interest and investment income
-
38.50M
1.33M
25.68M
Interest expense
-32.17M
-13.05M
-12.63M
-11.09M
Net interest expenses
-32.17M
25.45M
-11.30M
14.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
128.19M
271.08M
201.09M
252.56M
Gain or loss from assets sale
-1.84M
-
26.67K
-26.67K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps